Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

China · Delayed Price · Currency is CNY

100.08

+1.11 (1.12%)

Aug 14, 2026, 3:00 PM CST

82.36% (1Y)

Market Cap	21.34B +83.3%
Revenue (ttm)	3.00B +26.5%
Net Income	245.26M -0.8%
EPS	1.15 -2.5%
Shares Out	213.23M
PE Ratio	87.01
Forward PE	60.11
Dividend	0.23 (0.23%)
Ex-Dividend Date	Jul 13, 2026

Volume	6,285,206
Open	99.66
Previous Close	98.97
Day's Range	97.18 - 101.39
52-Week Range	54.11 - 102.60
Beta	0.59
Analysts	Strong Buy
Price Target	92.50 (-7.57%)
Earnings Date	Aug 27, 2026

About SHA:688131

Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2006

Employees 4,195

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688131

Full Company Profile

Financial Performance

In 2025, SHA:688131's revenue was 2.88 billion, an increase of 26.73% compared to the previous year's 2.27 billion. Earnings were 239.81 million, an increase of 18.96%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 688131 stock is "Strong Buy." The 12-month stock price target is ¥92.50, which is a decrease of -7.57% from the latest price.

Price Target

¥92.50

(-7.57% downside)

Analyst Consensus: Strong Buy

Stock Forecasts